These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1283440)

  • 21. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases.
    Panigrahi AK; Panda SK; Dixit RK; Rao KV; Acharya SK; Dasarathy S; Nanu A
    J Med Virol; 1997 Mar; 51(3):167-74. PubMed ID: 9139079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C antibodies in acute Non-A, Non-B hepatitis].
    Zellweger U; Havelka J; Zala G; Altorfer J; Joller-Jemelka HI; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):761-3. PubMed ID: 1711714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
    Imamura S
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Viral hepatitis C].
    Janković S
    Med Pregl; 1999; 52(11-12):459-63. PubMed ID: 10748768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of hepatitis C in Malaysia.
    Sinniah M
    Med J Malaysia; 1992 Sep; 47(3):155-7. PubMed ID: 1283439
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence and significance of anti-HCV antibodies.
    De Groote J
    Acta Gastroenterol Belg; 1991; 54(3-4):248-56. PubMed ID: 1665270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals?
    Verbaan H; Andersson K; Eriksson S
    Scand J Gastroenterol; 1993 Aug; 28(8):714-8. PubMed ID: 7692588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus. What recent studies can tell us.
    Dana F; Becherer PR; Bacon BR
    Postgrad Med; 1994 May; 95(6):121-2, 125-30. PubMed ID: 8170870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 33. New developments in hepatitis C.
    Reesink HW; Bresters D; van der Poel CL; Cuypers HT; Lelie PN
    Scand J Gastroenterol Suppl; 1992; 194():82-6. PubMed ID: 1298054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of hepatitis C in clinical practice: review of the literature].
    Brandão AB; Fuchs SC; Silva MA; Emer LF
    Rev Panam Salud Publica; 2001 Mar; 9(3):161-8. PubMed ID: 11349351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: a case-control study.
    Mele A; Sagliocca L; Manzillo G; Converti F; Amoroso P; Stazi MA; Ferrigno L; Rapicetta M; Franco E; Adamo B
    Am J Public Health; 1994 Oct; 84(10):1640-3. PubMed ID: 7943485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, virological and epidemiological basis for the treatment of chronic non-A, non-B hepatitis.
    Alter HJ
    J Hepatol; 1990; 11 Suppl 1():S19-25. PubMed ID: 1964164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural course of chronic hepatitis C.
    Iwarson S
    FEMS Microbiol Rev; 1994 Jul; 14(3):201-4. PubMed ID: 8086194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus antibody in Swaziland.
    Aceti A; Taliani G; Bruni R; Di Mauro G; Celestino D
    Acta Trop; 1992 Jun; 51(2):159-61. PubMed ID: 1380766
    [No Abstract]   [Full Text] [Related]  

  • 39. [Viral hepatitis C].
    Belaiche J
    Rev Med Liege; 1991 Aug; 46(8):405-13. PubMed ID: 1656507
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of screening and confirmation tests for antibodies to hepatitis C virus.
    Couroucé AM; Janot C
    Curr Stud Hematol Blood Transfus; 1994; (61):36-48. PubMed ID: 7525156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.